029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
RLN10014肺腺癌组织组合芯片，附病理分级、TNM和临床分期，50例/100点
点 数100例 数50
行 数10列 数10
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:RLN10014
 
肺腺癌组织微阵列芯片，包含腺癌50例，一例两点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Lun
-Lung
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIIA)
TISSUE  ARRAYS RLN10014
1
2
3
4
5
6
7
8
9
10
A
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
B
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
C
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
D
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
E
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
F
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
G
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
H
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
I
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
J
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1148MLungAdenocarcinoma1T1aN0M0IAMalignant3*3*3N
A2248MLungAdenocarcinoma1T1aN0M0IAMalignant3*3*3N
A3349MLungAdenocarcinoma with necrosis2T2aN0M0IBMalignant4.0*4.0*3.0N
A4449MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*4.0*3.0N
A5543FLungInvasive adenocarcinoma2T2N0M0IBMalignant*N
A6643FLungInvasive adenocarcinoma2T2N0M0IBMalignant*N
A7752MLungPapillary mucinous adenocarcinoma2T2bN0M0IIAMalignant*N
A8852MLungPapillary mucinous adenocarcinoma2T2bN0M0IIAMalignant*N
A9958FLungAdenocarcinoma2T2bN1M0IIBMalignant*N
A101058FLungAdenocarcinoma2T2bN1M0IIBMalignant*N
B11148FLungAdenocarcinoma2T2N0M0IBMalignant*N
B21248FLungAdenocarcinoma2T2N0M0IBMalignant*N
B31359MLungAdenocarcinoma2T2bN0M0IIAMalignant*N
B41459MLungAdenocarcinoma2T2bN0M0IIAMalignant*N
B51567MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*2.5*2.0N
B61667MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*2.5*2.0N
B71742MLungAdenocarcinoma2T2N0M0IBMalignant*N
B81842MLungAdenocarcinoma2T2N0M0IBMalignant*N
B91949MLungAdenocarcinoma2T2N0M0IBMalignant5.0N
B102049MLungAdenocarcinoma2T2N0M0IBMalignant5.0N
C12162MLungAdenocarcinoma2T2aN0M0IBMalignant4.5*4.0*3.0N
C22262MLungAdenocarcinoma2T2aN0M0IBMalignant4.5*4.0*3.0N
C32357MLungAdenocarcinoma with necrosis2T2bN0M0IIAMalignant5.0*4.5*4.5N
C42457MLungAdenocarcinoma2T2bN0M0IIAMalignant5.0*4.5*4.5N
C52563FLungAdenocarcinoma2T2N1M0IIBMalignant3.5*2.2*2N
C62663FLungAdenocarcinoma2T2N1M0IIBMalignant3.5*2.2*2N
C72754MLungAdenocarcinoma2T3N1M0IIIAMalignant8*6.5*6N
C82854MLungAdenocarcinoma2T3N1M0IIIAMalignant8*6.5*6N
C92958FLungAdenocarcinoma2T2aN0M0IBMalignant4*3*1.5N
C103058FLungAdenocarcinoma2T2aN0M0IBMalignant4*3*1.5N
D13154MLungAdenocarcinoma2T2bN2M0IIIAMalignant4.0*4.0*2.5N
D23254MLungAdenocarcinoma2T2bN2M0IIIAMalignant4.0*4.0*2.5N
D33365MLungAdenocarcinoma2T2aN2M0IIIAMalignant5.0*5.0*3.5N
D43465MLungAdenocarcinoma2T2aN2M0IIIAMalignant5.0*5.0*3.5N
D53539FLungAdenocarcinoma2T2aN0M0IBMalignant*N
D63639FLungAdenocarcinoma2T2aN0M0IBMalignant*N
D73772MLungAdenocarcinoma2T3N0M0IIBMalignant*N
D83872MLungAdenocarcinoma2T3N0M0IIBMalignant*N
D93958MLungAdenocarcinoma2T2bN0M0IIAMalignant*N
D104058MLungAdenocarcinoma2T2bN0M0IIAMalignant*N
E14148MLungInvasive adenocarcinoma with necrosis2T2N1M0IIBMalignant*N
E24248MLungInvasive adenocarcinoma with necrosis2T2N1M0IIBMalignant*N
E34365MLungAdenocarcinoma with necrosis2T2bN0M0IIAMalignant*N
E44465MLungAdenocarcinoma with necrosis2T2bN0M0IIAMalignant*N
E54564MLungAdenocarcinoma with necrosis2T2aN0M0IBMalignant*N
E64664MLungAdenocarcinoma with necrosis2T2aN0M0IBMalignant*N
E74765FLungAdenocarcinoma2T2bN2M0IIIAMalignant*N
E84865FLungAdenocarcinoma2T2bN2M0IIIAMalignant*N
E94961MLungAdenocarcinoma with necrosis2T2aN0M0IBMalignant4.0*3.5*3.0N
E105061MLungAdenocarcinoma with necrosis2T2aN0M0IBMalignant4.0*3.5*3.0N
F15162MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*3.5*3.0N
F25262MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*3.5*3.0N
F35344FLungAdenocarcinoma2T2aN0M0IBMalignant3.5*3.0*2.0N
F45444FLungAdenocarcinoma2T2aN0M0IBMalignant3.5*3.0*2.0N
F55550MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*3.5*1.5N
F65650MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*3.5*1.5N
F75759MLungAdenocarcinoma2T2N0M0IBMalignant5*2.5*2N
F85859MLungAdenocarcinoma2T2N0M0IBMalignant5*2.5*2N
F95972MLungSolid adenocarcinoma*T2N1M0IIBMalignant4.5*3.5*3.5N
F106072MLungSolid adenocarcinoma*T2N1M0IIBMalignant4.5*3.5*3.5N
G16153MLungAdenocarcinoma3T2N0M0IBMalignant*N
G26253MLungAdenocarcinoma3T2N0M0IBMalignant*N
G36370MLungAdenocarcinoma3T2aN2M0IIIAMalignant*N
G46470MLungAdenocarcinoma with necrosis3T2aN2M0IIIAMalignant*N
G56570MLungAdenocarcinoma3T2bN0M0IIAMalignant*N
G66670MLungAdenocarcinoma3T2bN0M0IIAMalignant*N
G76745FLungAdenocarcinoma3T2aN0M0IBMalignant*N
G86845FLungAdenocarcinoma3T2aN0M0IBMalignant*N
G96940MLungAdenocarcinoma3T2N0M0IBMalignant4.5N
G107040MLungAdenocarcinoma3T2N0M0IBMalignant4.5N
H17140MLungAdenocarcinoma (sparse)3T2N0M0IBMalignant6.0N
H27240MLungAdenocarcinoma (sparse)3T2N0M0IBMalignant6.0N
H37348MLungAdenocarcinoma3T2N0M0IBMalignant6.0N
H47448MLungAdenocarcinoma3T2N0M0IBMalignant6.0N
H57565MLungAdenocarcinoma with necrosis3T2N1M0IIBMalignant5*4*3.5N
H67665MLungAdenocarcinoma with necrosis3T2N1M0IIBMalignant5*4*3.5N
H77758MLungAdenocarcinoma with necrosis3T2N0M0IBMalignant6.5*4.5*3.5N
H87858MLungAdenocarcinoma (necrosis)*T2N0M0IBMalignant6.5*4.5*3.5N
H97958FLungAdenocarcinoma3T2aN0M0IBMalignant4.5*4.0*2.5N
H108058FLungAdenocarcinoma3T2aN0M0IBMalignant4.5*4.0*2.5N
I18165FLungAdenocarcinoma3T3N1M0IIIAMalignant*N
I28265FLungAdenocarcinoma3T3N1M0IIIAMalignant*N
I38343MLungAdenocarcinoma with necrosis3T2aN0M0IBMalignant5.0*3.0*2.5N
I48443MLungAdenocarcinoma3T2aN0M0IBMalignant5.0*3.0*2.5N
I58556FLungAdenocarcinoma3T2aN1M0IIBMalignant*N
I68656FLungAdenocarcinoma3T2aN1M0IIBMalignant*N
I78748MLungAdenocarcinoma3T3N1M0IIIAMalignant*N
I88848MLungAdenocarcinoma3T3N1M0IIIAMalignant*N
I98970MLungAdenocarcinoma3T3N1M0IIIAMalignant*N
I109070MLungAdenocarcinoma3T3N1M0IIIAMalignant*N
J19148FLungAdenocarcinoma3T2aN0M0IBMalignant*N
J29248FLungAdenocarcinoma3T2aN0M0IBMalignant*N
J39354MLungAdenocarcinoma3T2N0M0IBMalignant*N
J49454MLungAdenocarcinoma3T2N0M0IBMalignant*N
J59548MLungAdenocarcinoma3T2aN0M0IBMalignant*N
J69648MLungAdenocarcinoma3T2aN0M0IBMalignant*N
J79762MLungAdenocarcinoma3T2aN0M0IBMalignant*N
J89862MLungAdenocarcinoma3T2aN0M0IBMalignant*N
J99956FLungAdenocarcinoma3T2aN1M0IIBMalignant*N
J1010056FLungAdenocarcinoma3T2aN1M0IIBMalignant*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情